CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients.
Minuzzo
S
S
Indraccolo
S
S
Tosello
V
V
Piovan
E
E
Cabrelle
A
A
Trentin
L
L
Semenzato
G
G
Amadori
A
A
D015703:Antigens, CD / Q000378:metabolism*; D014408:Biomarkers, Tumor; D019013:CD40 Antigens / Q000378:metabolism*; D051925:CD79 Antigens; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D016130:Immunophenotyping; D015448:Leukemia, B-Cell / Q000378:metabolism* / Q000503:physiopathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D051562:Proto-Oncogene Proteins c-bcr
D015703:Antigens, CD; D014408:Biomarkers, Tumor; D019013:CD40 Antigens; D051925:CD79 Antigens; C497883:CD79B protein, human; D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr